US2009042299A1PendingUtilityA1
Vectors and methods for tissue specific synthesis of proteins in eggs of transgenic hens
Est. expiryJun 12, 2016(expired)· nominal 20-yr term from priority
Inventors:William C. Macarthur
A01K 2217/05A01K 2267/01A01K 2217/20A01K 2227/30C12N 15/86A01K 67/0275C12N 2740/10043C12N 15/8509
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Vectors and methods are provided for introducing genetic material into cells of a chicken or other avian species. More particularly, vectors and methods are provided for transferring a transgene to an embryonic chicken cell, so as to create a transgenic hen wherein the transgene is expressed in the hen's oviduct and the transgene product is secreted in the hen's eggs and/or those of her offspring. In a preferred embodiment, the transgene product is secreted in the egg white.
Claims
exact text as granted — not AI-modified1 . A replication-defective retroviral vector comprising:
a) a transgene; and b) control elements operatively-linked to the transgene and capable of directing synthesis of the transgene product in avian egg white, wherein the control elements comprise a promoter, a 5′ untranslated region and a signal sequence.
2 . The vector of claim 1 , wherein the replication-defective retroviral vector is derived from REV-A.
3 . The vector of claim 1 , wherein the promoter is chosen from the group consisting of the ovalbumin, lysozyme, conalbumin and ovomucoid promoters, and combinations thereof.
4 . The vector of claim 1 , wherein the avian is a chicken.
5 . The vector of claim 1 , wherein the control elements further comprise an enhancer.
6 . The vector of claim 3 , wherein the promoter comprises an ovalbumin promoter.
7 . The vector of claim 5 , wherein the enhancer comprises a steroid hormone response element.
8 . The vector of claim 5 , wherein the enhancer is a viral enhancer.
9 . The vector of claim 8 , wherein the enhancer is a portion of SV40.
10 . A replication-defective retroviral vector comprising:
a) a transgene; and b) control elements operatively-linked to the transgene and capable of directing synthesis of the transgene product in avian egg yolk, wherein the control elements comprise a promoter, a 5′ untranslated region, a signal sequence and an uptake sequence.
11 . The vector of claim 10 , wherein the replication-defective retroviral vector is derived from REV-A.
12 . The vector of claim 10 , wherein the promoter is chosen from the group consisting of the vitellogenin and apolipoprotein A promoters, and combinations thereof.
13 . The vector of claim 10 , wherein the avian is a chicken.
14 . The vector of claim 10 , wherein the control elements further comprise an enhancer.
15 . The vector of claim 14 , wherein the enhancer comprises a steroid hormone response element.
16 . The vector of claim 14 , wherein the enhancer is a viral enhancer.
17 . The vector of claim 16 , wherein the enhancer is a portion of SV40.
18 . A method for transferring a transgene to an embryonic chicken cell, comprising the step of introducing a replication-defective retroviral vector into the cell, wherein the vector comprises the transgene and control elements operatively-linked thereto and capable of directing the synthesis of the transgene product in egg white, wherein the control elements comprise a promoter, a 5′ untranslated region and a signal sequence.
19 . The method of claim 18 , wherein the replication-defective retroviral vector is derived from REV-A.
20 . The method of claim 18 , wherein the control elements further comprise an enhancer.Join the waitlist — get patent alerts
Track US2009042299A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.